{"id":"NCT01664247","sponsor":"Novo Nordisk A/S","briefTitle":"The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification","officialTitle":"The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10-01","primaryCompletion":"2013-12-31","completion":"2013-12-31","firstPosted":"2012-08-14","resultsPosted":"2016-04-20","lastUpdate":"2017-09-25"},"enrollment":346,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"liraglutide","otherNames":[]}],"arms":[{"label":"IDeg + Lira","type":"EXPERIMENTAL"},{"label":"Placebo + Lira","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Africa, Asia, Europe and North America. The purpose of the trial is to investigate the effect of insulin degludec (IDeg) in combination with liraglutide (Lira) and metformin (at least 1500 mg daily or maximum tolerated dose) in subjects with type 2 diabetes qualifying for treatment intensification.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Haemoglobin (HbA1c) (%)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"IDeg","deltaMin":-0.99,"sd":0.08},{"arm":"Placebo","deltaMin":-0.07,"sd":0.08}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":132,"countries":["United States","Canada","France","Germany","Israel","Italy","Serbia","South Africa","Ukraine","United Arab Emirates","United Kingdom"]},"refs":{"pmids":["26990378"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":173},"commonTop":["Nasopharyngitis","Diarrhoea","Lipase increased"]}}